Reproductive & Child Health Programme
Community Medicine · National Health Programmes · lean revision notes
Reproductive & Child Health Programme
The Reproductive & Child Health (RCH) programme is the flagship maternal–child health initiative of India's National Health Mission. It is examined heavily for its components, the PC-PNDT Act, ANC service standards, and entitlement schemes like JSSK and JSY. This topic rewards exact numbers (visit counts, IFA doses, TT schedules), so memorise the figures cold.
Evolution & classification of the programme
India's maternal–child health policy has passed through several named phases. Knowing the sequence and the defining feature of each phase is a recurring MCQ.
| Phase / Programme | Year | Defining feature |
|---|---|---|
| Maternal & Child Health (MCH) | 1952 (with FP) | Vertical, target-driven, fragmented |
| Child Survival & Safe Motherhood (CSSM) | 1992 | Integrated MCH + immunisation + ORT |
| RCH-I | 1997 | "Target-free" / community-needs approach; added RTI/STI care |
| RCH-II | 2005 | Launched with NRHM; outcome-oriented, decentralised |
| RMNCH+A | 2013 | Adds Adolescent health + continuum of care |
High-yield: RCH-II was launched in 2005 alongside the National Rural Health Mission (NRHM). RCH-I (1997) introduced the "target-free approach" replacing the old method-specific contraceptive targets.
The current overarching strategy is RMNCH+A (Reproductive, Maternal, Newborn, Child and Adolescent Health), built on the continuum of care — across life stages (adolescence → pregnancy → birth → childhood) and across levels (home/community → facility).
RCH-II major components
- Maternal health — promotion of institutional delivery (JSY), skilled birth attendance, emergency obstetric care (EmOC), safe abortion (MTP) services.
- Child health — IMNCI (Integrated Management of Neonatal & Childhood Illness), immunisation, vitamin A, control of diarrhoea (ORS/zinc) and ARI.
- Family planning — spacing and limiting methods, NSV (no-scalpel vasectomy), expanded contraceptive choice.
- Adolescent health — later expanded as RKSK (Rashtriya Kishor Swasthya Karyakram, 2014).
- RTI/STI management and urban RCH.
High-yield: The two new components RCH-I added over CSSM were RTI/STI management and adolescent/reproductive health needs with a client-centred, target-free approach.
Antenatal care (ANC) — service package
ANC is the most frequently tested subtopic. Two number sets compete in MCQs — the traditional Indian programmatic minimum and the WHO 2016 recommendation.
| Parameter | Traditional/Indian programme | WHO 2016 model |
|---|---|---|
| Number of contacts | Minimum 4 visits | 8 contacts |
| First visit timing | As early as possible, within first trimester (≤12 wk) | First contact ≤12 wk |
| Schedule | 1st: ≤12 wk; 2nd: 14–26 wk; 3rd: 28–34 wk; 4th: 36 wk–term | 1, then 20, 26, 30, 34, 36, 38, 40 wk |
High-yield: The earlier WHO "focused ANC" recommended 4 visits, but the 2016 WHO ANC model upgraded this to 8 contacts to reduce perinatal mortality. India's programme minimum remains 4 ANC visits; under PMSMA an additional assured second/third-trimester checkup is given on the 9th of every month.
Minimum ANC services (the "package")
Remember these as the must-do components at every/early contact:
- History & registration (ideally first trimester).
- Two doses of tetanus toxoid / Td — TT1 at first contact, TT2 four weeks later; a booster is given if pregnant within 3 years of a fully immunised pregnancy. (Programme has shifted from TT to Td vaccine.)
- Iron–folic acid (IFA) supplementation.
- Calcium supplementation (added later).
- Blood pressure monitoring (screen for pre-eclampsia).
- Weight & anaemia (Hb) assessment, abdominal examination, fetal heart sounds, presentation/lie.
- Urine for albumin & sugar; blood grouping/Rh; VDRL, HIV, HBsAg screening; blood sugar.
- Counselling on nutrition, danger signs, birth preparedness, institutional delivery.
IFA dosing — memorise exactly
| Group | Elemental iron + folic acid | Duration |
|---|---|---|
| Pregnancy — prophylaxis | 60 mg iron + 500 µg folic acid, 1 tablet/day | Throughout pregnancy + 100 days postpartum (≥180 tablets) |
| Pregnancy — anaemia (Hb <11) | Two tablets/day (120 mg iron) | Until Hb normalises, then prophylactic dose |
| Lactation / 100 days postpartum | 60 mg iron + 500 µg folic acid daily | 100 days |
High-yield: Each pregnancy IFA tablet contains 60 mg elemental iron + 500 µg folic acid; the woman receives at least 180 tablets (100 days antenatal + 100 days postnatal). Anaemia in pregnancy is defined as Hb < 11 g/dL (WHO); severe anaemia <7 g/dL.
The wider strategy is Anaemia Mukt Bharat (AMB) — the 6×6×6 framework (6 interventions, 6 target groups, 6 institutional mechanisms) with the colour-coded National Iron Plus Initiative (pink tablets for pregnant/lactating, blue for children 6 m–5 y, etc.).
High-yield: Pre-pregnancy / periconceptional folic acid to prevent neural tube defects is 400 µg/day in low-risk women and 4 mg (4000 µg)/day in high-risk women (previous NTD child, on antiepileptics).
Diagnosis & danger-sign recognition (approach)
A pregnant woman's risk stratification flow during ANC:
Register & history → measure BP + weight + Hb → abdominal exam (fundal height, lie, FHS) → urine albumin/sugar → screen VDRL/HIV/HBsAg → classify as low-risk vs high-risk → high-risk referral to FRU.
High-risk markers include: BP ≥140/90, Hb <7, height <140 cm, bad obstetric history, malpresentation after 32 weeks, multiple pregnancy, post-dated, and medical disorders (diabetes, heart disease).
Danger signs warranting urgent referral — mnemonic "BLEEDS-CHF": Bleeding PV, Leaking, Edema (face/hands), Epigastric pain, Diminished fetal movements, Severe headache/blurred vision; Convulsions, High fever, Fast/difficult breathing.
Intranatal & postnatal care
Institutional, skilled birth attendance is the core RCH goal. The partograph (WHO) monitors labour; the alert line and action line guide referral — crossing the alert line in a peripheral facility mandates transfer to a Comprehensive EmOC centre.
Postnatal care (PNC) schedule
High-yield: Recommended postnatal home/facility contacts for normal delivery are on days 1, 3, 7, and 42 (some texts add day 14). For home deliveries the schedule is days 1, 3, 7 and 6 weeks. The first 24–48 hours carry the highest risk of postpartum haemorrhage and neonatal death.
PNC includes assessment for bleeding, sepsis, breast condition, contraception counselling, exclusive breastfeeding support, and newborn care (warmth, early initiation of breastfeeding within 1 hour, weighing, immunisation).
Key government schemes under RCH
Janani Suraksha Yojana (JSY) — 2005
A conditional cash-transfer scheme to promote institutional delivery, especially among poor women. Cash assistance differs by state category (Low Performing vs High Performing States) and rural/urban setting.
| Setting | Mother's cash (LPS) | Mother's cash (HPS) |
|---|---|---|
| Rural | ₹1400 | ₹700 |
| Urban | ₹1000 | ₹600 |
High-yield: Under JSY, the ASHA acts as the link worker and receives a package for facilitating institutional delivery. In Low-Performing States, all pregnant women delivering in govt/accredited facilities are eligible regardless of age or birth order; in HPS, eligibility is restricted (BPL/SC/ST, age ≥19, up to 2 live births).
Janani Shishu Suraksha Karyakram (JSSK) — 2011
A landmark free-entitlement scheme abolishing all out-of-pocket spending for pregnant women and sick neonates in public facilities.
High-yield — JSSK entitlements (very frequently asked): Free and cashless delivery (including caesarean), free drugs & consumables, free diagnostics, free diet (up to 3 days for normal delivery, 7 days for caesarean), free blood, free transport (home→facility, referral between facilities, and drop-back within 48 hours). The same entitlements extend to sick newborns up to 30 days (later extended to infants up to 1 year under the expanded JSSK). No user charges of any kind.
Mnemonic for JSSK free items — "D-D-D-D-B-T": Delivery, Drugs, Diagnostics, Diet, Blood, Transport.
Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) — 2016
Assured, comprehensive and quality ANC on the 9th of every month, free of cost, by an OBGYN/physician for all pregnant women in their 2nd/3rd trimester.
Pradhan Mantri Matru Vandana Yojana (PMMVY)
Maternity-benefit cash transfer (₹5000 in instalments) for the first living child to compensate wage loss; recently a second-child benefit added if the child is a girl.
LaQshya — Labour Room Quality Improvement Initiative (2017)
High-yield: LaQshya aims to improve quality of care in labour rooms and maternity operation theatres, reduce maternal & newborn mortality and ensure respectful maternity care. Facilities achieving ≥70% on assessment get state, then national certification, and those scoring ≥90% get the "LaQshya-certified" branding with incentives. (Compare with Kayakalp = cleanliness/hygiene awards; Muskaan = child-friendly; NQAS = National Quality Assurance Standards.)
SUMAN (Surakshit Matritva Aashwasan, 2019)
Assured, dignified, zero-expense and zero-tolerance-for-denial maternal & newborn care, consolidating earlier free-service guarantees.
PC-PNDT Act, 1994 — sex determination law
This is the single most examined legal topic in this chapter.
The Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, amended in 2003 (the words "Pre-conception" and "sex selection" added to cover techniques chosen before conception). Enacted to arrest the falling child sex ratio.
High-yield: The Act prohibits sex selection before or after conception, and prohibits advertisement relating to pre-natal/pre-conception sex determination. It does NOT ban prenatal diagnosis itself — diagnosis for detecting genetic/metabolic/chromosomal abnormalities or congenital anomalies is permitted; only communicating/determining the sex of the foetus is banned.
What is prohibited
- Conducting or aiding sex selection on a man, woman, or gametes/embryo.
- Determining or disclosing the sex of the foetus by words, signs, or any manner.
- Advertising sex-selection/determination facilities (including online) — punishable.
- Sale of ultrasound/scanning machines to unregistered units.
Permitted prenatal indications (for genetic testing, NOT sex)
Age >35 years, ≥2 spontaneous abortions, exposure to teratogens, family history of genetic disease/mental retardation, or other condition specified by the Board — these justify diagnostic procedures, but the sex must never be revealed.
Penalties — memorise the numbers
| Offence | Punishment |
|---|---|
| Medical professional (1st offence) — sex selection/determination | Up to 3 years imprisonment + fine up to ₹10,000 |
| Subsequent offence (doctor) | Up to 5 years + fine up to ₹50,000 |
| Person seeking sex selection (1st offence) | Up to 3 years + up to ₹50,000 fine |
| Subsequent offence (seeker) | Up to 5 years + up to ₹1,00,000 fine |
| Doctor's name | Reported to State Medical Council → suspension/removal from register |
High-yield: On a first conviction a doctor faces up to 3 years + ₹10,000, with the name forwarded to the State Medical Council for suspension during pendency and removal on conviction. The pregnant woman is presumed to have been compelled by relatives unless proven otherwise (a protective presumption).
The Appropriate Authority (district/state level) enforces registration and prosecution; every clinic must maintain Form F records and display that sex determination is illegal. The genetic counselling centre/lab/clinic must be registered.
High-yield: MTP (Medical Termination of Pregnancy) Act and PC-PNDT are different — MTP regulates when abortion is legal (recently up to 24 weeks for special categories under the 2021 amendment); PC-PNDT prevents sex-selective abortion. They are complementary, not the same.
Complications & programme indicators
Key impact indicators the RCH programme targets (know definitions):
- Maternal Mortality Ratio (MMR) = maternal deaths per 1,00,000 live births.
- Infant Mortality Rate (IMR) = infant deaths per 1000 live births.
- Neonatal Mortality Rate (NMR), Under-5 mortality, Total Fertility Rate (TFR).
High-yield (SDG targets): SDG 3 aims for MMR < 70/100,000, NMR ≤ 12/1000, and U5MR ≤ 25/1000 by 2030. India's MMR has fallen below 100; TFR has reached replacement level (~2.0).
Key differentials / "don't confuse these"
| Pair | Distinction |
|---|---|
| JSY vs JSSK | JSY = conditional cash incentive for institutional delivery; JSSK = free entitlements (no payment) for mother + newborn |
| RCH-I vs RCH-II | RCH-I (1997, target-free + RTI/STI); RCH-II (2005, with NRHM, outcome-based) |
| LaQshya vs Kayakalp | LaQshya = labour room/OT quality; Kayakalp = facility cleanliness/hygiene awards |
| PMSMA vs PMMVY | PMSMA = free ANC checkup on the 9th; PMMVY = maternity cash benefit |
| PC-PNDT vs MTP Act | PC-PNDT = bans sex selection; MTP = legalises abortion within limits |
Recently asked / exam angle
- Number of ANC visits: WHO 2016 model = 8 contacts; Indian programme minimum = 4. Examiners test both — read the question stem carefully.
- IFA tablet content in pregnancy: 60 mg elemental iron + 500 µg folic acid; total ≥180 tablets (100 antenatal + 100 postnatal days).
- JSSK free diet duration: 3 days normal, 7 days caesarean; newborn cover up to 30 days (extended to 1 year).
- PC-PNDT first-offence penalty for doctor: 3 years + ₹10,000, name to State Medical Council.
- Year of RCH-II = 2005 (with NRHM); PC-PNDT enacted 1994, amended 2003.
- LaQshya = labour room & maternity OT quality improvement (often paired with Kayakalp/Muskaan as distractors).
- Postpartum IFA / 100 days rule and 400 µg vs 4 mg periconceptional folic acid for NTD prevention.
- Td has replaced TT in the maternal immunisation schedule.
Rapid revision
- RCH-II launched 2005 alongside NRHM; current umbrella = RMNCH+A (2013) with continuum of care.
- RCH-I (1997) = target-free approach + added RTI/STI and adolescent health.
- ANC minimum in India = 4 visits; WHO 2016 model = 8 contacts; first contact by 12 weeks.
- Pregnancy IFA = 60 mg iron + 500 µg folic acid/day, ≥180 tablets (100 antenatal + 100 postnatal); anaemia = double dose.
- Anaemia in pregnancy = Hb < 11 g/dL; severe <7 g/dL — refer.
- Periconceptional folic acid: 400 µg low-risk, 4 mg high-risk (prior NTD/antiepileptics).
- Td (formerly TT) — 2 doses 4 weeks apart; booster if pregnant within 3 years.
- PNC contacts: days 1, 3, 7, 42 (highest risk in first 48 h — PPH and neonatal death).
- JSY = conditional cash transfer for institutional delivery; JSSK (2011) = free delivery, drugs, diagnostics, diet, blood, transport — mother + newborn (≤30 days).
- PC-PNDT 1994 (amended 2003) bans sex selection/determination & advertisement, NOT prenatal diagnosis; doctor's 1st-offence penalty 3 yrs + ₹10,000.
- PMSMA = free assured ANC on the 9th of every month; LaQshya = labour room/OT quality improvement.
- SDG 2030 maternal–child targets: MMR <70/lakh, NMR ≤12/1000, U5MR ≤25/1000.